Bio-Techne
TECH
#1485
Rank
ยฃ9.19 B
Marketcap
ยฃ57.84
Share price
0.24%
Change (1 day)
-3.93%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

P/E ratio for Bio-Techne (TECH)

P/E ratio as of December 2024 (TTM): 46.0

According to Bio-Techne's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 46.0446. At the end of 2022 the company had a P/E ratio of 49.6.

P/E ratio history for Bio-Techne from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202249.6-48.47%
202196.238.09%
202069.662.43%
201942.9-24.75%
201857.035.46%
201742.1-9.6%
201646.538.04%
201533.714.55%
201429.4-3.64%
201330.533.61%
201222.92.13%
201122.42.24%
201021.9-10.6%
200924.57.4%
200822.8-18.19%
200727.90.02%
200627.9-10.56%
200531.211.33%
200428.0-9.06%
200330.8-21.34%
200239.1-6.57%
200141.9

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
33.8-26.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-57.1-223.91%๐Ÿ‡บ๐Ÿ‡ธ USA
40.8-11.36%๐Ÿ‡บ๐Ÿ‡ธ USA
28.6-37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
30.7-33.23%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
19.7-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.7479-101.62%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.